53.0	Venlafaxine	Venlafaxine	Venlafaxine is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class. First introduced by Wyeth in 1993, now marketed by Pfizer, it is licensed for the treatment of major depressive disorder (MDD), as a treatment for generalized anxiety disorder, and comorbid indications in certain anxiety disorders with depression. In 2007, venlafaxine was the sixth most commonly prescribed antidepressant on the U.S. retail market, with 17.2 million prescriptions.	http://upload.wikimedia.org/wikipedia/commons/thumb/6/67/Venlafaxine.svg/200px-Venlafaxine.svg.png
